Access the full text.
Sign up today, get DeepDyve free for 14 days.
Koller WC (1984)
Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigsPsychopharmacology, 84
Craig TJ Richardson MA (1982)
Intra-patient variability in the measurement of tardive dyskinesiaPsychopharmacology, 76
J. Kane, J. Smith (1982)
Tardive dyskinesia: prevalence and risk factors, 1959 to 1979Journal of Clinical Psychopharmacology, 2
W. Glazer, D. Moore, N. Schooler, L. Brenner, H. Morgenstern (1984)
Tardive dyskinesia. A discontinuation study.Archives of general psychiatry, 41 6
S. Mukherjee, S. Shukla, A. Rosen (1984)
Neurological abnormalities in patients with bipolar disorder.Biological psychiatry, 19 3
N. Cutler, R. Post, A. Rey, W. Bunney (1981)
Depression-dependent dyskinesias in two cases of manic-depressive illness.The New England journal of medicine, 304 18
R. Yassa, Ghadirian Am, G. Schwartz (1983)
Prevalence of tardive dyskinesia in affective disorder patients.The Journal of clinical psychiatry, 44 11
G. Gárdos, J. Cole (1983)
The prognosis of tardive dyskinesia.The Journal of clinical psychiatry, 44 5
Cole JO Baldessarini RJ (1980)
Tardive Dyskinesia: Task Force Report 18
J. Defries, S. Singer, T. Foch, F. Lewitter (1978)
Familial Nature of Reading DisabilityBritish Journal of Psychiatry, 132
S. Mukherjee, A. Rosen, C. Cárdenas, V. Varia, S. Olarte (1982)
Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variablesJournal of Clinical Psychopharmacology, 2
D. Gallager, A. Pert, W. Bunney (1978)
Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithiumNature, 273
D. Jeste, M. Linnoila, C. Fordis, B. Phelps, R. Wagner, R. Wyatt (1982)
Enzyme Studies in Tardive Dyskinesia. III. Noradrenergic Hyperactivity in a Subgroup of Dyskinetic PatientsJournal of Clinical Psychopharmacology, 2
Kucharski LT Smith JM (1979)
An assessment of tardive dyskinesia in schizophrenic outpatientsPsychopharmacology, 64
Belmaker RH Bannet J (1980)
The effects of drug holidays in an animal model of tardive dyskinesiaPsychopharmacology, 69
M. Rupniak, P. Jenner, C. Marsden (1983)
The effect of chronic neuroleptic administration on cerebral dopamine receptor function.Life sciences, 32 20
Astrup C Stephens JH (1982)
A comparison of nine diagnostic systems to diagnose schizophreniaPsychiatry Res, 6
D. Dunner, R. Fieve (1974)
Clinical factors in lithium carbonate prophylaxis failure.Archives of general psychiatry, 30 2
Johnstone EC Owens DGC (1982)
Spontaneous involuntary disorders of movement in neuroleptic treated and untreated chronic schizophrenics: Prevalence, severity, and distributionsArch Gen Psychiatry, 39
M. Alpert, F. Diamond, A. Friedhoff (1976)
Tremographic studies in tardive dyskinesia.Psychopharmacology bulletin, 12 2
Shukla S Mukherjee S (1984)
Neurological abnormalities in bipolar patientsBiol Psychiatry, 19
T. Crow, A. Cross, E. Johnstone, F. Owen, D. Owens, J. Waddington (1982)
Abnormal Involuntary Movements in Schizophrenia: Are They Related to the Disease Process or Its Treatment? Are They Associated with Changes in Dopamine Receptors?Journal of Clinical Psychopharmacology, 2
S. Mukherjee, A. Wiśniewski, R. Bilder, H. Sackeim (1985)
Possible association between tardive dyskinesia and altered carbohydrate metabolism.Archives of general psychiatry, 42 2
D. Jeste, R. Wyatt (1981)
Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?The Journal of clinical psychiatry, 42 12
R. Smith, M. Strizich, D. Klass (1978)
Drug history and tardive dyskinesia.The American journal of psychiatry, 135 11
DeVaugh-Geiss J Carey RJ (1984)
Treatment schedule as a determinant of the development of tolerance to haloperidolPsychopharmacology, 82
M. Silverstein, R. Warren, M. Harrow, R. Grinker, T. Pawelski (1982)
Changes in diagnosis from DSM-II to the research diagnostic criteria and DSM-III.The American journal of psychiatry, 139 3
J. Kane, F. Struve, P. Weinhold, M. Woerner (1980)
Strategy for the study of patients at high risk for tardive dyskinesia.The American journal of psychiatry, 137 10
Niven RG Rosenbaum AH (1977)
Tardive dyskinesia: Relationship with primary affective disorderDis Nerv Syst, 38
M. Rush, F. Diamond, M. Alpert (1982)
Depression as a risk factor in tardive dyskinesia.Biological psychiatry, 17 3
Endicott J Spitzer RL (1979)
Schedule for Affective Disorders and Schizophrenia: Life-time Version
D. Jeste, S. Potkin, S. Sinha, S. Feder, R. Wyatt (1979)
Tardive dyskinesia--reversible and persistent.Archives of general psychiatry, 36 5
Wyatt RJ Jeste DV (1980)
Changing epidemiology of tardive dyskinesiaAm J Psychiatry, 138
Robinson HE Severson JA (1984)
Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: Relationship to dose and drugPsychopharmacology, 84
R. Yassa, J. Archer, S. Cordozo (1984)
The Long-Term Effect of Lithium Carbonate on Tardive DyskinesiaThe Canadian Journal of Psychiatry, 29
Rosen AM Mukherjee S (1982)
Tardive dyskinesia in psychiatric outpatientsArch Gen Psychiatry, 39
A. Gibson (1978)
Depot Injections and Tardive DyskinesiaBritish Journal of Psychiatry, 133
J. Singer (1983)
Clozapine and tardive dyskinesia.Archives of general psychiatry, 40 3
Jackson-Lewis V Reches A (1984)
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brainPsychopharmacology, 82
R. Potter, P. Linkowski, Julien Mendlewicz (1983)
State-dependent tardive dyskinesia in manic-depressive illness.Journal of Neurology, Neurosurgery & Psychiatry, 46
A. Mackay, G. Sheppard, B. Saha, B. Motley, A. Johnson, C. Marsden (1980)
Failure of lithium treatment in established tardive dyskinesiaPsychological Medicine, 10
D. Lozovsky, C. Saller, I. Kopin (1983)
Lithium and the prevention of dopamine receptor supersensitivity in diabetic rats.The American journal of psychiatry, 140 5
A. Jus, A. Villeneuve, J. Gautier, K. Jus, C. Villeneuve, P. Pires, R. Villeneuve (1978)
Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.Neuropsychobiology, 4 3
F. Quitkin, A. Rifkin, L. Gochfeld, D. Klein (1977)
Tardive dyskinesia: are first signs reversible?The American journal of psychiatry, 134 1
Yagi G (1978)
Reversible tardive dyskinesia: Its onset and long-term prognosisSeishin-Igaku, 20
R. Post (1980)
Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance.Life sciences, 26 16
Wooten GF Rubin EH (1984)
The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivityPsychopharmacology, 84
D. Staunton, P. Magistretti, W. Shoemaker, S. Deyo, F. Bloom (1982)
Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivityBrain Research, 232
D. Burt, D. Burt, I. Creese, SolomonH Snyder (1977)
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.Science, 196 4287
J. Kane, M. Woerner, P. Weinhold, J. Wegner, B. Kinon (1982)
A Prospective Study of Tardive Dyskinesia Development: Preliminary ResultsJournal of Clinical Psychopharmacology, 2
G. Gárdos, J. Cole, R. Brie (1977)
Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis.Progress in neuro-psychopharmacology, 1 1-2
A. Pert, J. Rosenblatt, C. Sivit, C. Pert, W. Bunney (1978)
Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.Science, 201 4351
W. Sant, G. Ellison (1984)
Drug holidays alter onset of oral movements in rats following chronic haloperidol.Biological psychiatry, 19 1
Villeneuve A Jus A (1978)
Deanol, lithium and placebo in the treatment of tardive dyskinesiaNeuropsychobiology, 4
Smith JM Kane JM (1982)
Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979Arch Gen Psychiatry, 39
Gardos G Cole JO (1984)
Tardive Dyskinesia and Affective Disorders
M. Wolf, J. Ryan, A. Mosnaim (1983)
Cognitive functions in tardive dyskinesiaPsychological Medicine, 13
B. Hamra, H. Nasrallah, J. Clancy, R. Finn (1983)
Psychiatric diagnosis and risk for tardive dyskinesia.Archives of general psychiatry, 40 3
G. Gárdos, J. Cole (1980)
Problems in the Assessment of Tardive Dyskinesia
Post RM (1980)
Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or toleranceBiol Psychiatry, 26
R. Yassa, V. Nair, George Schwartz (1984)
Tardive dyskinesia and the primary psychiatric diagnosisJournal of Clinical Psychopharmacology, 4
D. Owens, E. Johnstone, C. Frith (1982)
Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.Archives of general psychiatry, 39 4
K. Davis, P. Berger, L. Hollister (1976)
Tardive dyskinesia and depressive illness.Psychopharmacology communications, 2 2
Overstreet DH Crocker AD (1984)
Modification of the behavioral effects of haloperidol and of dopamine receptor regulation by altered thyroid statusPsychopharmacology, 82
Jakubovic A Pittman KJ (1984)
The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the ratPsychopharmacology, 82
Cole JO Gardos G (1980)
Tardive Dyskinesia: Research and Treatment
N. Schooler, J. Kane (1982)
Research diagnoses for tardive dyskinesia.Archives of general psychiatry, 39 4
J. Waddington, A. Cross, S. Gamble, R. Bourne (1983)
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.Science, 220 4596
Wyatt Rj (1976)
Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literature.Psychopharmacology Bulletin, 12
Burki HR Sayers AC (1975)
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesia: Effects of clozapine, haloperidol, loxapine, and chlorpromazinePsychopharmacologia, 41
D. Jeste, R. Wyatt (1981)
Changing epidemiology of tardive dyskinesia: an overview.The American journal of psychiatry, 138 3
Abstract • The prevalence and outcome of persistent tardive dyskinesia (TD) was studied in 131 bipolar patients. There were 34 cases of persistent TD in the subgroup (n = 96) with a history of neuroleptic treatment (prevalence, 35.4%; 95% confidence interval, 25% to 45%); there were no cases of persistent TD in the subgroup (n = 35) without such treatment history. Except in one patient, signs of TD persisted in spite of lithium carbonate treatment in 23 patients (median duration, 16 months; range, five to 24 months), of whom 15 remained off of a neuroleptic regimen during the study period for a median duration of 14 months (range, four to 24 months). Using multiple regression analysis, two variables were found to predict the presence of persistent TD and account for 36% of the variance: longer cumulative duration of maintenance neuroleptic treatment and shorter duration of previous lithium carbonate treatment. There appears to be a significant risk of persistent TD among neuroleptic-treated bipolar patients. High-risk subgroups within this category need to be identified. References 1. Owens DGC, Johnstone EC, Frith CD: Spontaneous involuntary disorders of movement in neuroleptic treated and untreated chronic schizophrenics: Prevalence, severity, and distributions . Arch Gen Psychiatry 1982;39:452-461.Crossref 2. Crow TJ, Cross AJ, Johnstone EC, Owen F, Owens DGC, Waddington JL: Abnormal involuntary movements in schizophrenia: Are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors? J Clin Psychopharmacol 1982;2:336-340.Crossref 3. Kane JM, Smith JM: Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979 . Arch Gen Psychiatry 1982;39:473-481.Crossref 4. Davis KL, Berger PA, Hollister LE: Tardive dyskinesia and depressive illness . Psychopharmacol Commun 1976;2:125-130. 5. Alpert M, Diamond F, Friedhoff A: Tremorographic studies in tardive dyskinesia . Psychopharmacol Bull 1976;12:5-7. 6. Rosenbaum AH, Niven RG, Hanson NP, Swanson DW: Tardive dyskinesia: Relationship with primary affective disorder . Dis Nerv Syst 1977;38:423-427. 7. Kane J, Struve FA, Weinhold P, Woerner M: Strategy for the study of patients at high risk for tardive dyskinesia . Am J Psychiatry 1980;137:1265-1267. 8. Rush M, Diamond F, Alpert M: Depression as a risk factor in tardive dyskinesia . Biol Psychiatry 1982;17:387-392. 9. Hamra BJ, Nasrallah H, Clancy J, Finn R: Psychiatric diagnosis and risk for tardive dyskinesia . Arch Gen Psychiatry 1983;40:347-348.Crossref 10. Yassa R, Ghadirian AM, Schwartz G: Prevalence of tardive dyskinesia in affective disorder patients . J Clin Psychiatry 1983;44:410-412. 11. Yassa R, Nair V, Schwartz G: Tardive dyskinesia and the primary psychiatric diagnosis . Psychosomatics 1984;25:135-138.Crossref 12. Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B: A prospective study of tardive dyskinesia development: Preliminary results . J Clin Psychopharmacol 1982;2:345-349. 13. Gardos G, Casey DE (eds): Tardive Dyskinesia and Affective Disorders . Washington, DC, American Psychiatric Press Inc, 1984. 14. Smith JM, Kucharski LT, Eblen C, Knutsen E, Linn C: An assessment of tardive dyskinesia in schizophrenic outpatients . Psychopharmacology 1979;64:99-104.Crossref 15. Mukherjee S, Rosen AM, Cardenas CC, Varia VV, Olarte S: Tardive dyskinesia in psychiatric outpatients . Arch Gen Psychiatry 1982;39:466-469.Crossref 16. Schooler NR, Kane JM: Research diagnoses for tardive dyskinesia . Arch Gen Psychiatry 1982;39:486-487. 17. Silverstein ML, Warren RA, Harrow M, Grinker RR, Pawelski T: Changes in diagnosis from DSMII to the Research Diagnostic Criteria and DSM III . Am J Psychiatry 1982;139:366-368. 18. Stephens JH, Astrup C, Carpenter WT, Shaffer JW, Goldberg J: A comparison of nine diagnostic systems to diagnose schizophrenia . Psychiatry Res 1982;6:127-143.Crossref 19. Spitzer RL, Endicott J: Schedule for Affective Disorders and Schizophrenia: Life-time Version , ed 3. New York, New York State Psychiatric Institute, Biometrics Research, 1979. 20. Dunner DL, Fieve RR: Clinical factors in lithium carbonate prophylaxis failure . Arch Gen Psychiatry 1974;30:229-233.Crossref 21. Guy W: ECDEU Assessment Manual for Psychopharmacology, US Dept of Health, Education, and Welfare publication 76-338. Psychopharmacology Research Branch, 1976. 22. Gardos G, Cole JO: Problems in the assessment of tardive dyskinesia , in Fann WE, Smith RC, Davis JM, Domino EF (eds): Tardive Dyskinesia: Research and Treatment . New York, SP Medical & Scientific Books, 1980, pp 201-214. 23. Richardson MA, Craig TJ, Branchey MH: Intra-patient variability in the measurement of tardive dyskinesia . Psychopharmacology 1982;76:269-272.Crossref 24. Cutler NR, Post RM, Rey AC, Bunney WE Jr: Depression-dependent dyskinesias in two cases of manic-depressive illness . N Engl J Med 1981;304:1088-1089.Crossref 25. De Potter RW, Linkowski P, Mendlewicz J: State-dependent tardive dyskinesia in manic-depressive illness . J Neurol Neurosurg Psychiatry 1983;46:666-668.Crossref 26. Mukherjee S, Shukla S, Rosen A: Neurological abnormalities in bipolar patients . Biol Psychiatry 1984;19:337-345. 27. Jeste DV, Wyatt RJ: Changing epidemiology of tardive dyskinesia . Am J Psychiatry 1980;138:297-309. 28. Baldessarini RJ, Cole JO, Davis JM, Gardos G, Preskorn SH, Simpson GM, Tarsy D: Tardive Dyskinesia: Task Force Report 18 . Washington, DC, American Psychiatric Association, 1980. 29. Casey D: Tardive dyskinesia and affective disorders , in Gardos G, Casey D (eds): Tardive Dyskinesia and Affective Disorders . Washington, DC, American Psychiatric Press Inc, 1984, pp 1-20. 30. Gardos G, Cole JO: The prognosis of tardive dyskinesia . J Clin Psychiatry 1983;44:177-179. 31. Glazer WM, Moore DC, Schooler NR, Brenner LM, Morgenstern H: Tardive dyskinesia: A discontinuation study . Arch Gen Psychiatry 1984;41:623-627.Crossref 32. Gardos G, Cole JO, La Brie R: Drug variables in the etiology of tardive dyskinesia: Application of discriminant function analysis . Prog Neuropsychopharmacol 1977;1:147-154.Crossref 33. Jeste DV, Potkin SG, Sinha S, Feder S, Wyatt RJ: Tardive dyskinesia: Reversible and persistent . Arch Gen Psychiatry 1979;36:585-590.Crossref 34. Gibson AC: Depot injections and tardive dyskinesia . Br J Psychiatry 1978;132:361-365.Crossref 35. Quitkin F, Rifkin A, Gochfield L, Klein DF: Tardive dyskinesia: Are first signs reversible? Am J Psychiatry 1977;134:84-87. 36. Yagi G: Reversible tardive dyskinesia: Its onset and long-term prognosis . Seishin-Igaku 1978;20:49-58. 37. Kane JM, Woerner M, Weinhold P, Kinon B, Lieberman J, Borenstein M: Incidence and severity of tardive dyskinesia in affective illness , in Gardos G, Casey DE (eds): Tardive Dyskinesia and Affective Disorders . Washington, DC, American Psychiatric Press Inc, 1984, pp 21-28. 38. Bannet J, Belmaker RH, Ebstein RP: The effects of drug holidays in an animal model of tardive dyskinesia . Psychopharmacology 1980;69:223-224.Crossref 39. Sant WW, Ellison G: Drug holidays alter onset of oral movements in rats following chronic haloperidol . Biol Psychiatry 1984;19:95-99.Crossref 40. Koller WC: Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigs . Psychopharmacology 1984;84:98-100.Crossref 41. Burt DR, Creese I, Snyder SH: Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain . Science 1977;196:326-328.Crossref 42. Sayers AC, Burki HR, Ruch W, Asper H: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesia: Effects of clozapine, haloperidol, loxapine, and chlorpromazine . Psychopharmacologia 1975;41:97-104.Crossref 43. Carey RJ, DeVaugh-Geiss J: Treatment schedule as a determinant of the development of tolerance to haloperidol . Psychopharmacology 1984;82:164-167.Crossref 44. Post RM: Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance . Biol Psychiatry 1980;26:1275-1282. 45. Smith RC, Strizich M, Klass D: Drug history in tardive dyskinesia . Am J Psychiatry 1978;135:1402-1403. 46. Rupniak NMJ, Jenner P, Marsden CD: The effect of chronic neuroleptic administration on cerebral dopamine receptor function . Life Sci 1983;32:2289-2311.Crossref 47. Severson JA, Robinson HE, Simpson GM: Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: Relationship to dose and drug . Psychopharmacology 1984;84:115-119.Crossref 48. Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WE Jr: Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity . Science 1978;201:171-173.Crossref 49. Gallager DW, Pert A, Bunney WE Jr: Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium . Nature 1978;273:309-312.Crossref 50. Lozovsky D, Sailer CF, Kopin I: Lithium and the prevention of dopamine receptor supersensitivity in diabetic rats . Am J Psychiatry 1983;140:613-614. 51. Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE: Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum: II. No effect on denervation or neuroleptic-induced supersensitivity . Brain Res 1982;232:401-412.Crossref 52. Reches A, Jackson-Lewis V, Fahn S: Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain . Psychopharmacology 1984;82:330-334.Crossref 53. Pittman KJ, Jakubovic A, Fibiger HC: The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat . Psychopharmacology 1984;82:371-377.Crossref 54. Rubin EH, Wooten GF: The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity . Psychopharmacology 1984;84:217-220.Crossref 55. Jeste DV, Wyatt RJ: Dogma disputed: Is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? J Clin Psychiatry 1981;42:455-457. 56. Jeste DV, Linnoila M, Fordis CM, Phelps BH, Wagner RL, Wyatt RJ: Enzyme studies in tardive dyskinesia: III. Noradrenergic hyperactivity in a subgroup of dyskinetic patients . J Clin Psychopharmacol 1982;2:318-320. 57. Waddington JL, Cross AJ, Gamble SJ, Bourne RC: Spontaneous orofacial dyskinesia and dopaminergic function in rats after six months of neuroleptic treatment . Science 1983;220:530-532.Crossref 58. Jus A, Villeneuve A, Gautier G, Jus K, Villeneuve C, Pires P, Villeneuve R: Deanol, lithium and placebo in the treatment of tardive dyskinesia . Neuropsychobiology 1978;4:140-149.Crossref 59. Mackay AVP, Sheppard GP, Saha BK, Motley B, Johnson AL, Marsden CD: Failure of lithium treatment in established tardive dyskinesia . Psychol Med 1980;10:583-587.Crossref 60. Yassa R, Archer J, Cordozo S: The long-term effects of lithium carbonate on tardive dyskinesia . Can J Psychiatry 1982;29:36-37. 61. Cole JO, Gardos G, Rapkin RM, Gelertner J, Haskell D, Moore P, Schniebolk S, Bird M: Lithium carbonate in tardive dyskinesia and schizophrenia , in Gardos G, Casey D (eds): Tardive Dyskinesia and Affective Disorders . Washington, DC, American Psychiatric Press Inc, 1984, pp 49-73. 62. Wolf M, Ryan JJ, Mosnaim AD: Cognitive functions in tardive dyskinesia . Psychol Med 1983;13:671-674.Crossref 63. Mukherjee S, Wisniewski A, Bilder RM, Sackeim HA: A probable association between tardive dyskinesia and altered carbohydrate metabolism . Arch Gen Psychiatry 1985;42:205.Crossref 64. Crocker AD, Overstreet DH: Modification of the behavioral effects of haloperidol and of dopamine receptor regulation by altered thyroid status . Psychopharmacology 1984;82:102-106.Crossref
Archives of General Psychiatry – American Medical Association
Published: Apr 1, 1986
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.